kanamycin a has been researched along with Bacteremia in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (44.44) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 3 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dzierzbicka, K; Kukowska, M; Kukowska-Kaszuba, M | 1 |
Araoka, H; Baba, M; Kimura, M; Moriya, K; Okada, C; Sato, T; Yatomi, Y; Yoneyama, A | 1 |
Bolscher, JG; Canizalez-Román, A; Flores-Villaseñor, H; Leon-Sicairos, N; Nazmi, K; Velazquez-Roman, J | 1 |
GENTILINI, M; HAZARD, J | 1 |
MARTIN, WJ; MCHENRY, MC | 1 |
ANSELL, JS; BOURNE, HH; KENNEDY, RP; PETERSDORF, RG; PLORDE, JJ | 1 |
BIEGELEISEN, JZ; CHERRY, WB; KASS, EH; MAIZTEGUI, JI | 1 |
Maezawa, H; Nakazawa, Y; Saito, A; Sakai, O; Sakamoto, M; Saruta, K; Shiba, K; Shindo, N; Yoshida, M; Yoshikawa, K | 1 |
Fujikawa, T; Kobayashi, I; Matsumoto, T; Miyazaki, S; Tateda, K; Yamaguchi, K | 1 |
1 trial(s) available for kanamycin a and Bacteremia
Article | Year |
---|---|
Sepsis associated with hematological malignancies: prophylaxis of Pseudomonas aeruginosa sepsis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Bacteremia; Ciprofloxacin; Drug Therapy, Combination; Female; Humans; Kanamycin; Leukemia; Lymphoma; Male; Middle Aged; Polymyxin B; Pseudomonas Infections; Retrospective Studies | 1996 |
8 other study(ies) available for kanamycin a and Bacteremia
Article | Year |
---|---|
In vitro studies of antimicrobial activity of Gly-His-Lys conjugates as potential and promising candidates for therapeutics in skin and tissue infections.
Topics: Anti-Infective Agents; Bacteremia; Escherichia coli; Fungi; Humans; Microbial Sensitivity Tests; Oligopeptides; Pseudomonas aeruginosa; Skin Diseases, Bacterial; Staphylococcus aureus | 2015 |
Risk Factors for Recurrent Helicobacter cinaedi Bacteremia and the Efficacy of Selective Digestive Decontamination With Kanamycin to Prevent Recurrence.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Decontamination; Female; Gastrointestinal Tract; Helicobacter; Helicobacter Infections; Humans; Incidence; Kanamycin; Male; Medical Records; Middle Aged; Recurrence; Retrospective Studies; Risk Factors; Secondary Prevention | 2018 |
Protective effects of lactoferrin chimera and bovine lactoferrin in a mouse model of enterohaemorrhagic Escherichia coli O157:H7 infection.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacteremia; Cattle; Drug Therapy, Combination; Escherichia coli Infections; Escherichia coli O157; Feces; Intestines; Kanamycin; Kidney; Lactoferrin; Liver; Male; Mice; Mice, Inbred BALB C | 2012 |
[COLIBACILLARY SEPTICEMIA AND BACTEREMIA IN ADULTS. APROPOS OF 14 CASES OF SEPTICEMIA].
Topics: Abortion, Septic; Bacteremia; Chloramphenicol; Cholangitis; Colistin; Escherichia coli Infections; Gastroenteritis; Hydrocortisone; Kanamycin; Polymyxins; Prognosis; Sepsis; Shock, Septic; Streptomycin; Urinary Tract Infections | 1964 |
BACTEREMIA DUE TO GRAM-NEGATIVE BACILLI. RESUME OF EXPERIENCES IN 303 CASES.
Topics: Aging; Angiotensins; Bacteremia; Bacteroides; Chloramphenicol; Colistin; Drug Therapy; Enterobacter aerogenes; Escherichia coli Infections; Humans; Iatrogenic Disease; Kanamycin; Metaraminol; Polymyxins; Postoperative Complications; Proteus; Pseudomonas Infections; Sepsis; Sex; Streptomycin; Sympatholytics; Tetracycline; Urinary Tract Infections | 1964 |
COURSE AND PROGNOSIS OF PROSTATECTOMY: WITH A NOTE ON THE INCIDENCE OF BACTEREMIA AND EFFECTIVENESS OF CHEMOPROPHYLAXIS.
Topics: Aged; Bacteremia; Blood Urea Nitrogen; Chemoprevention; Drug Therapy; Geriatrics; Humans; Incidence; Kanamycin; Male; Nitrofurantoin; Postoperative Complications; Preoperative Care; Preventive Medicine; Prognosis; Prostatectomy; Prostatic Hyperplasia; Prostatic Neoplasms; Sepsis; Urinary Tract Infections; Urography | 1965 |
BACTEREMIA DUE TO GRAM-NEGATIVE RODS. A CLINICAL, BACTERIOLOGIC, SEROLOGIC AND IMMUNOFLUORESCENT STUDY.
Topics: Acinetobacter; Bacteremia; Chloramphenicol; Diabetes Mellitus; Drug Resistance; Drug Resistance, Microbial; Enterobacter; Escherichia coli; Fluorescent Antibody Technique; Kanamycin; Klebsiella; Liver Cirrhosis; Polymyxins; Proteus; Pseudomonas; Salmonella; Sepsis; Streptomycin; Tetracycline; Urinary Tract Infections | 1965 |
Development of systemic bacteraemia after oral inoculation of vancomycin-resistant enterococci in mice.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Bacterial Translocation; Cyclophosphamide; Drug Therapy, Combination; Enterococcus; Escherichia coli; Gram-Positive Bacterial Infections; Immunosuppressive Agents; Intestines; Kanamycin; Metronidazole; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Inbred ICR; Mice, Nude; Mice, SCID; Neutropenia; Vancomycin; Vancomycin Resistance; Virulence | 2001 |